Study characteristics on health-related quality of life in older people living with human immunodeficiency virus: A narrative review

Table 3 Methods of eligible studies reported in the narrative review (n = 68)

Studies	Number of studies (%)	P value1
Age cut-off
Cut-off of 50	50 (73.53)	0.0001
Other	10 (14.71)
Not available	8 (11.76)
Terminology use
HRQoL	33 (48.53)	NS
QoL	26 (38.24)
HRQoL or QoL	3 (4.41)
Well-being	2 (2.94)
Other	4 (5.88)
Conceptual/Theoretical frameworks used
Wilson and Cleary	3 (4.41)	< 0.0001
Other	9 (13.24)
None	56 (82.35)
Instrument use
MOS-HIV	10 (14.71)	< 0.0001
SF survey	20 (29.41)
WHOQOL-HIV BREF	9 (13.24)
FAHI QoL	5 (7.35)
EuroQoL-5D-3 L	5 (7.35)
HAT-QoL	4 (5.88)
Others	15 (22.06)
Study designs
Cross-sectional study	61 (89.71)	< 0.0001
Follow-up study	7 (10.29)
Statistical modeling tests
Linear regression model	41 (60.29)	NS
Logistic regression model	9 (13.24)
Structural equation model	6 (8.82)
Hierarchical regression model	4 (5.88)
Other	8 (11.76)
Outcome measures
HRQoL	18 (26.47)	0.029
Physical-HRQoL or mental-HRQoL	19 (27.94)
QoL	25 (36.76)
Other	6 (8.82)

¹Two-sided binomials for one sample.

EuroQoL-5D-3 L: European QoL 5-Dimension 3-Level version; FAHIQoL: Functional Assessment of HIV Infection Quality of Life; HAT-QoL: HIV/AIDS-target quality of life; HRQoL: Health-related Quality of Life; MOS-HIV: Medical Outcomes Study HIV Health Survey; QoL: Quality of life; SF survey: Short form survey; WHOQOL-HIV BREF: World Health Organization Quality of Life brief; NS: Not significant.